Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Rohto Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	602,986	505,369	676,888	631,946	421,488	336,849
Market Cap Growth	-5.08%	-25.34%	7.11%	49.93%	25.13%	-0.24%
Enterprise Value	588,903	493,570	610,616	575,682	380,505	296,984
Last Close Price	2668.50	2218.10	2904.20	2690.13	1778.18	1407.26
PE Ratio	17.19	16.30	21.88	23.96	20.05	20.12
Forward PE	18.15	15.19	20.08	24.15	19.94	21.85
PS Ratio	1.81	1.64	2.50	2.65	2.11	1.86
PB Ratio	2.06	1.86	2.74	2.94	2.29	2.15
P/TBV Ratio	2.91	2.48	2.86	3.16	2.49	2.27
P/FCF Ratio	19.02	18.16	25.77	28.15	24.82	29.84
P/OCF Ratio	14.71	13.69	19.77	20.43	15.47	16.84
PEG Ratio	3.56	4.00	4.00	4.00	4.00	4.00
EV/Sales Ratio	1.76	1.60	2.26	2.41	1.91	1.64
EV/EBITDA Ratio	10.32	9.56	12.50	13.93	10.61	10.38
EV/EBIT Ratio	14.62	12.83	15.20	17.17	13.50	13.58
EV/FCF Ratio	18.58	17.73	23.25	25.64	22.41	26.31
Debt / Equity Ratio	0.16	0.19	0.04	0.05	0.12	0.05
Debt / EBITDA Ratio	0.83	0.97	0.21	0.28	0.60	0.28
Debt / FCF Ratio	1.49	1.80	0.40	0.52	1.26	0.72
Asset Turnover	0.79	0.80	0.83	0.82	0.80	0.82
Inventory Turnover	2.34	2.47	2.59	2.72	2.71	2.55
Quick Ratio	1.47	1.55	1.82	1.75	1.74	1.79
Current Ratio	2.17	2.30	2.47	2.37	2.30	2.36
Return on Equity (ROE)	12.90%	11.94%	13.59%	13.25%	12.42%	11.31%
Return on Assets (ROA)	5.90%	6.26%	7.66%	7.17%	7.04%	6.20%
Return on Invested Capital (ROIC)	11.73%	13.63%	19.28%	18.52%	17.47%	14.91%
Return on Capital Employed (ROCE)	11.90%	11.80%	15.50%	14.60%	13.90%	12.90%
Earnings Yield	5.93%	6.13%	4.57%	4.17%	4.99%	4.97%
FCF Yield	5.26%	5.51%	3.88%	3.55%	4.03%	3.35%
Dividend Yield	1.65%	1.62%	0.93%	0.82%	1.01%	1.00%
Payout Ratio	22.86%	22.81%	17.70%	17.73%	16.28%	17.71%
Buyback Yield / Dilution	-0.53%	-0.04%	0.00%	0.00%	-	-0.01%
Total Shareholder Return	1.13%	1.58%	0.93%	0.82%	1.01%	0.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.